Abstract
Receptor-mediated increases in intracellular Ca2+ levels can be caused by release from intracellular organelles and/or influx from the extracellular fluid. Noradrenaline (NA) released from sympathetic nerves acts on α1-adrenoceptors to increase cytosolic Ca2+ and promote smooth muscle contraction1. In many cells activation of α1-adrenoceptors causes formation of inositol 1,4,5-trisphosphate which promotes Ca2+ release from intracellular stores2,3. The mechanism by which receptor activation opens cell surface Ca2+ channels is not known, although in some cases it may be secondary to formation of inositol phosphates4,5 or release of stored intracellular Ca2+ (ref. 3). However α1-adrenoceptors have recently been shown to have different pharmacological properties in different tissues6–9, and it has been proposed that different α1-adrenoceptor subtypes may control mobilization of intracellular Ca2+ and gating of extracellular Ca2+ influx7,9,10–12. We here report evidence for two subtypes of α1-adrenoceptors which cause contractile responses through different molecular mechanisms. One subtype stimulates inositol phosphate (InsP) formation and causes contractions which are independent of extracellular Ca2+, and the other does not stimulate inositol phosphate formation and causes contractions which require the influx of extracellular Ca2+ through dihydropyridine-sensitive channels. These results suggest that neurotransmitters and hormones may control Ca2+ release from intracellular stores and influx through voltage-gated membrane channels through distinct receptor subtypes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cauvin, C., Loutzenhiser, R. & van Breeman, C. V. A. Rev. Pharmac. Toxicol. 23, 373–396 (1983).
Berridge, M. J. & Irvine, R. F. Nature 312, 315–321 (1984).
Putney, J. W. Am. J. Physiol. 252, G149–G157 (1987).
Irvine, R. F. and Moore, R. M. Biochem. J. 240, 917–920 (1986).
Kuno, M. & Gardner, P. Nature 326, 301–304 (1987).
Coates, J., Jahn, U. & Weetman, D. F. Br. J. Pharmac. 75, 549–552 (1982).
McGrath, J. C. Br. J. Pharmac 79, 227P (1983).
Morrow, A. L. & Creese, I. Molec. Pharmac. 29, 321–330 (1986).
Hieble, J. P., DeMarinis, R. M. & Matthews, W. D. Life Sci. 38, 1339–1350 (1986).
Beckeringh, J. J. et al. J. Pharmac. exp. Ther. 229, 515–521 (1984).
Matthews, W. D. et al. J. Pharmacol. exp. Ther. 232, 330–336 (1985).
Jim, K. F., Macia, R. A. & Matthews, W. D. J. Pharmac. exp. Ther. 237, 377–381 (1985).
Johnson, R. D. & Minneman, K. P. Molec. Pharmac. 31, 239–246 (1987).
LeClerc, B., Rouot, B., Schwartz, J., Velly, J. & Wemuth, C. G. Br. J. Pharmac. 71, 5–9 (1980).
Engel, G. & Hoyer, D. Eur. J. Pharmac. 73, 221–224 (1981).
Han, C., Abel, P. W. & Minneman, K. P. Molec. Pharmac. (in the press).
Minneman, K. P. & Abel, P. W. Molec Pharmac. 25, 56–63 (1984).
Munson, P. J. & Rodbard, D. Analyt. Biochem. 107, 220–239 (1980).
Cheng, Y.-C. & Prusoff, W. H. Biochem. Pharmac. 22, 2099–3108 (1973).
Prpic, V., Green, K. C., Blackmore, P. F. & Exton, J. H. J. biol. Chem. 259, 1382–1385 (1984).
Minneman, K. P., Fox, A. W. & Abel, P. W. Molec. Pharmac. 23, 359–368 (1983).
Amhed, M. I. & Naylor, I. L. Br. J. Pharmac. 77, 538P (1982).
Fox, A. W., Abel, P. W. & Minneman, K. P. Eur. J. Pharmac. 116, 145–152 (1985).
Arunlakshana, O. & Schild, H. O. Br. J. Pharmac 14, 48–58 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Han, C., Abel, P. & Minneman, K. α1Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature 329, 333–335 (1987). https://doi.org/10.1038/329333a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/329333a0
This article is cited by
-
Subtypes of functional α1-adrenoceptor
Cellular and Molecular Life Sciences (2010)
-
Arg347Cys polymorphism of α1A-adrenoceptor gene is associated with blood pressure response to nifedipine GITS in Chinese hypertensive patients
Journal of Human Genetics (2009)
-
α1‐Adrenoceptors are required for normal male sexual function
British Journal of Pharmacology (2007)
-
Correlation between vasoconstrictor roles and mRNA expression of α1‐adrenoceptor subtypes in blood vessels of genetically engineered mice
British Journal of Pharmacology (2005)
-
Sympathectomy reveals α1A‐ and α1D‐adrenoceptor components to contractions to noradrenaline in rat vas deferens
British Journal of Pharmacology (2004)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.